HK1197085A1 - Genetic variants for predicting risk of breast cancer - Google Patents

Genetic variants for predicting risk of breast cancer

Info

Publication number
HK1197085A1
HK1197085A1 HK14110581A HK14110581A HK1197085A1 HK 1197085 A1 HK1197085 A1 HK 1197085A1 HK 14110581 A HK14110581 A HK 14110581A HK 14110581 A HK14110581 A HK 14110581A HK 1197085 A1 HK1197085 A1 HK 1197085A1
Authority
HK
Hong Kong
Prior art keywords
breast cancer
genetic variants
predicting risk
predicting
risk
Prior art date
Application number
HK14110581A
Other languages
English (en)
Chinese (zh)
Inventor
Patrick Sulem
Simon Stacey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1197085A1 publication Critical patent/HK1197085A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00—Subject matter not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK14110581A 2011-06-16 2014-10-23 Genetic variants for predicting risk of breast cancer HK1197085A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS50016 2011-06-16
PCT/IS2012/050009 WO2012172575A1 (fr) 2011-06-16 2012-06-14 Variants génétiques pour prédire le risque de cancer du sein

Publications (1)

Publication Number Publication Date
HK1197085A1 true HK1197085A1 (en) 2015-01-02

Family

ID=47356620

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14110581A HK1197085A1 (en) 2011-06-16 2014-10-23 Genetic variants for predicting risk of breast cancer

Country Status (4)

Country Link
US (1) US20140329719A1 (fr)
EP (1) EP2721180A4 (fr)
HK (1) HK1197085A1 (fr)
WO (1) WO2012172575A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10323285B2 (en) * 2013-09-09 2019-06-18 Nantomics, Llc Proteomics analysis and discovery through DNA and RNA sequencing, systems and methods
CN104035889B (zh) * 2014-06-18 2017-02-22 中国人民解放军信息工程大学 一种多态路由派生方法及系统
MX2017006028A (es) * 2014-11-06 2018-01-23 Ancestryhealth Com Llc Prediccion de resultados de salud.
WO2016100049A1 (fr) 2014-12-18 2016-06-23 Edico Genome Corporation Transistor à effet de champ chimiquement sensible
US10020300B2 (en) 2014-12-18 2018-07-10 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US9857328B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same
US9859394B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US9618474B2 (en) 2014-12-18 2017-04-11 Edico Genome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US10006910B2 (en) 2014-12-18 2018-06-26 Agilome, Inc. Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same
WO2017201081A1 (fr) 2016-05-16 2017-11-23 Agilome, Inc. Dispositifs à fet au graphène, systèmes et leurs méthodes d'utilisation pour le séquençage d'acides nucléiques
WO2019075251A2 (fr) * 2017-10-12 2019-04-18 Nantomics, Llc Score de cancer pour l'évaluation et la prévision de réponse à partir de fluides biologiques
TWI661198B (zh) * 2018-01-26 2019-06-01 長庚大學 診斷或預斷人類口腔癌的方法
CN113707222A (zh) * 2021-07-28 2021-11-26 邢传华 用于预测预定疾病风险的方法、计算设备和存储介质

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070092900A1 (en) * 2005-10-26 2007-04-26 Stacey Simon N Methods for diagnosing and characterizing breast cancer and susceptibility to breast cancer
EP2540840A3 (fr) * 2007-03-26 2013-05-15 Decode Genetics EHF. Variants génétiques du CHR16 utilisés comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein
MX2009012722A (es) * 2007-05-25 2009-12-11 Decode Genetics Ehf Variantes geneticas sobre chr 5p12 y 10q26 como marcadores para el uso en la evaluacion del riesgo, diagnostico, pronostico y tratamiento del cancer de mama.
WO2009042975A1 (fr) * 2007-09-26 2009-04-02 Navigenics, Inc. Procédés et systèmes pour l'analyse génomique à l'aide de données ancestrales
WO2009097270A2 (fr) * 2008-01-28 2009-08-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Procédé de détermination du risque du cancer du sein
JP2011527565A (ja) * 2008-07-07 2011-11-04 ディコーデ ジェネテクス イーエイチエフ 乳癌のリスクアセスメントのための遺伝的変異

Also Published As

Publication number Publication date
EP2721180A1 (fr) 2014-04-23
US20140329719A1 (en) 2014-11-06
EP2721180A4 (fr) 2015-09-02
WO2012172575A1 (fr) 2012-12-20

Similar Documents

Publication Publication Date Title
IL276488B (en) A method for predicting breast cancer prognosis
HK1197085A1 (en) Genetic variants for predicting risk of breast cancer
EP2686443A4 (fr) Variants génétiques utiles pour l'estimation du risque d'un cancer de la thyroïde
IL228738A0 (en) Antibodies for cancer treatment
HK1254859A1 (zh) 治療乳腺癌的方法
HK1201413A1 (en) Treatment of breast cancer
HK1197182A1 (en) Cancer immunotherapy
EP2691547A4 (fr) Prédicteurs d'expression génique pour le pronostic du cancer
EP2698634A4 (fr) Biomarqueur pour le cancer du sein
GB201102014D0 (en) Method for predicting risk of developing cancer
EP2648754A4 (fr) Méthodes d'inhibition de la métastase d'un cancer
EP2707710A4 (fr) Diagnostic de cancer
IL228430A0 (en) Cancer treatment
GB201120860D0 (en) Cancer immunotherapy
GB2510539B (en) Biomarkers of cancer
EP2894477A4 (fr) Procédé de dépistage du cancer du sein
EP2771695A4 (fr) Procédé de détection de cancers du sein
EP2649225A4 (fr) Biomarqueurs pour la prédiction du cancer du sein
EP2732287A4 (fr) Procédés de diagnostic du cancer
GB201103407D0 (en) Genetic association
EP2769225A4 (fr) Marqueurs biologiques prédictifs pour le cancer du sein
IL229109A0 (en) Cancer diagnosis
AP3297A (en) Direct electrowinning of cobalt
GB201121783D0 (en) Treatment of cancer
GB201222952D0 (en) Treatent of cancer